Annual Kind-Phillipp-Meeting in Wilsede 2025
At this years Kind-Philipp-Meeting our team joined with a record breaking 21 talks. David was awarded the Kind-Philipp-Presentation Award for his excellent contribution.
At this years Kind-Philipp-Meeting our team joined with a record breaking 21 talks. David was awarded the Kind-Philipp-Presentation Award for his excellent contribution.
Our group joined the DFG Research Unit RU5433 Retreat with the focus on RNA function in Friedrichsdorf. We contributed exciting talks and developed new ideas for our RNA projects in pediatric AML.
We were honoured to film a segment with José Carerras and his team for his 30th charity gala. The clip was streamed along side others and celebrity guest acts, leading to a donation sum of over 3.5 Mio Euros.
At this years 5th Rhein-Main Cancer Retreat in Glasshütte the leukemia research group contributed with three outstanding talks by our group leaders, which were accompanied by a total of seven posters.
Welcoming us and international experts the UCT, FCI and the DKTK with their cutting edge conference about cancer research. Filled with exiting talks and posters, held at the Westend Campus of the Goethe-University.
Awarded as the newest members of the Max-Eder-Nachwuchsprogramm junior group leaders Marit and Hannah received a combined amount of 1.5 mio Euros in funding to support their research aims.
A commentary giving insights on Sato et al.'s comprehensive genomic analysis and functional validation. A study advancing our understanding of the genetic factors that influence TAM to ML-DS progression.
Our research group being represented at EHA 2024 with three presentations and two posters, sharing our work on pediatric leukemia.
Like every year the leukemia research group makes it way to the north of Germany for the annual Kind-Phillip-Meeting for an insightful conference about pediatric cancers.
The latest episode of a regional news outlet on German television network SAT.1 featured Prof.Klusmann and Prof.Heckl. The interview gives insights on possible applications of micro RNAs in cancer therapies.